Impact Factor 3.845 | CiteScore 3.92
More on impact ›

Original Research ARTICLE Provisionally accepted The full-text will be published soon. Notify me

Front. Pharmacol. | doi: 10.3389/fphar.2019.00860

Importance of increasing modifiable risk factors knowledge on Alzheimer’s disease among community pharmacists and general practitioners in Spain.

Mónica Alacreu1,  Juan Pardo1, María Azorín1,  María Teresa Climent2, Vicente Gasull3 and  Lucrecia Moreno1*
  • 1Universidad CEU Cardenal Herrera, Spain
  • 2Sociedad Española de Farmacia Familiar y Comunitaria ( SEFAC ), Spain
  • 3Spanish Society of Primary Care Physicians, Spain

Community pharmacists and general practitioners have daily contact with patients with Alzheimer’s disease (AD) but the number of positive cases constantly increases every day. Thus, the aim of this research is to describe the level of AD knowledge among community pharmacists and general practitioners in Spain, in order to see which are the most striking lacks to face with guaranties this conjuncture. Therefore a cross-sectional study has been carried out, using the Alzheimer's disease knowledge survey (ADKS), among members of the Spanish Society of Primary Care Physicians and the Spanish Society of Family and Community Pharmacy to discover it to report the differences in AD knowledge in both professional collectives.
The ADKS has been responded by 578 community pharmacists and 104 general practitioners and consists of a battery of 30 questions, whose possible answers are true or false. It assesses the AD knowledge in seven areas (impact on the disease, risk factors, course of the disease, diagnosis, care, treatment and symptoms). Results indicate that Spanish pharmacists and general practitioners have a high score and personal knowledge of AD, nevertheless, it is not associated with greater awareness. Both scored above 80% at the categories: diagnostic, treatment and symptoms. However, lower knowledge level (60% of correct answers) was found to in those related to risk factors, such as the ignorance about hypercholesterolemia or hypertension as risk factors for the disease. Community pharmacists are already acting to control cardiovascular risk factors, but a wider knowledge of the relationship of these factors to AD is needed to act against these silent risk factors. Thus, pharmacists may also be involved in the management of AD that includes recognizing early symptoms for early detection of cognitive impairment. Hence, knowledge about risk factors is very important to develop this expanding role.

Keywords: Alzheheimer's disease, Risk factors, Community pharmacist knowledge, General practitioner knowledge, Knowledge scale, ADKS

Received: 13 Apr 2019; Accepted: 05 Jul 2019.

Edited by:

Ileana Mardare, Carol Davila University of Medicine and Pharmacy, Romania

Reviewed by:

Dušanka M. Krajnović, Faculty of Pharmacy, University of Belgrade, Serbia
Fernando Martinez Martinez, University of Granada, Spain  

Copyright: © 2019 Alacreu, Pardo, Azorín, Climent, Gasull and Moreno. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Prof. Lucrecia Moreno, Universidad CEU Cardenal Herrera, Valencia, 46115, Spain, lmoreno@uchceu.es